E-LIB Suche - Ergebnisse für: van Engen, Anke

1

PP22 A Lifecycle Approach To The Use Of Real-World Evidence..:

Samaha, Dima ; Tavares, Eliana ; van Engen, Anke.
International Journal of Technology Assessment in Health Care. 38 (2022) S1 - p. S47-S47 , 2022

Link: https://doi.org/10.1017/..

2

A call to action to harmonize patient-reported outcomes evi..:

Chassany, Olivier ; Engen, Anke van ; Lai, Livia...
Future Oncology. 18 (2022) 29 - p. 3323-3334 , 2022

Link: https://doi.org/10.2217/..

3

Author's Reply:

Patel, Dony ; van Engen, Anke ; Kim, Joseph
Value in Health. 25 (2022) 7 - p. 1256 , 2022

Link: https://doi.org/10.1016/..

4

PP96 Joint Clinical Assessments – Implementation And Lesson..:

Samaha, Dima ; Newton, Max ; Tavares, Eliana...
International Journal of Technology Assessment in Health Care. 38 (2022) S1 - p. S72-S72 , 2022

Link: https://doi.org/10.1017/..

5

Use of External Comparators for Health Technology Assessmen..:

Patel, Dony ; Grimson, Fiona ; Mihaylova, Elena...
Value in Health. 24 (2021) 8 - p. 1118-1125 , 2021

Link: https://doi.org/10.1016/..

6

"De-escalation" strategy using micafungin for the treatment..:

van Engen, Anke ; Casamayor, Montserrat ; Kim, Soyoung..
ClinicoEconomics and Outcomes Research. 9 (2017) - p. 763-774 , 2017

Link: https://doi.org/10.2147/..

7

Cost-effectiveness of a fixed-dose combination of solifenac..:

Nazir, Jameel ; Heemstra, Lars ; van Engen, Anke..
BMC Urology. 15 (2015) 1 - p. , 2015

Link: https://doi.org/10.1186/..

8

Pharmacoeconomic model of topical treatment options of mild..:

Augustin, Matthias ; Radtke, Marc ; Van Engen, Anke...
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 7 (2009) 4 - p. 329-338 , 2009

Link: https://doi.org/10.1111/..

9

Pharmakoökonomisches Modell zur Kosten‐Effektivität topisch..:

Augustin, Matthias ; Radtke, Marc ; Engen, Anke van...
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 7 (2009) 4 - p. 329-339 , 2009

Link: https://doi.org/10.1111/..

10

Structure and Total Synthesis of HF-7, a Neuroactive Glycon..:

McCormick, Jinping ; Li, Yingbo ; McCormick, Kevin...
Journal of the American Chemical Society. 121 (1999) 24 - p. 5661-5665 , 1999

Link: https://doi.org/10.1021/..

11

Use of external comparators for health technology assessmen..:

Patel, Dony ; Grimson, Fiona ; Mihaylova, Elena...
http://eprints.lse.ac.uk/111000/1/Use_of_External_Comparators_for_Health_Technology_Assessment.pdf. , 2021

Link: http://eprints.lse.ac.uk..

12

"De-escalation" strategy using micafungin for the treatment..:

van Engen, Anke ; Casamayor, Montserrat ; Kim, Soyoung..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722012/. , 2017

Link: http://www.ncbi.nlm.nih...

13

"De-escalation" strategy using micafungin for the treatment..:

van Engen, Anke ; Casamayor, Montserrat ; Kim, Soyoung..
info:eu-repo/semantics/altIdentifier/doi/10.2147/CEOR.S141548. , 2017

Link: https://www.dovepress.co..

14

Cost-effectiveness of a fixed-dose combination of solifenac..:

Nazir, Jameel ; Heemstra, Lars ; van Engen, Anke..
http://www.biomedcentral.com/1471-2490/15/41. , 2015

Link: http://www.biomedcentral..

15

Cost-effectiveness analysis of fidaxomicin versus vancomyci..:

Nathwani, Dilip ; Cornely, Oliver A ; Van Engen, Anke K...
Nathwani , D , Cornely , O A , Van Engen , A K , Odufowora-Sita , O , Retsa , P & Odeyemi , I A O 2014 , ' Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection ' Journal of Antimicrobial Chemotherapy , vol 69 , no. 11 , pp. 2901-2912 . DOI:10.1093/jac/dku257. , 2014

Link: http://discovery.dundee...